KR20110133573A - Composition for oral cavity - Google Patents

Composition for oral cavity Download PDF

Info

Publication number
KR20110133573A
KR20110133573A KR1020117022572A KR20117022572A KR20110133573A KR 20110133573 A KR20110133573 A KR 20110133573A KR 1020117022572 A KR1020117022572 A KR 1020117022572A KR 20117022572 A KR20117022572 A KR 20117022572A KR 20110133573 A KR20110133573 A KR 20110133573A
Authority
KR
South Korea
Prior art keywords
copper
composition
effect
betaine
oral cavity
Prior art date
Application number
KR1020117022572A
Other languages
Korean (ko)
Other versions
KR101649003B1 (en
Inventor
코타 츠츠미
마사토 마루야마
Original Assignee
라이온 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라이온 가부시키가이샤 filed Critical 라이온 가부시키가이샤
Publication of KR20110133573A publication Critical patent/KR20110133573A/en
Application granted granted Critical
Publication of KR101649003B1 publication Critical patent/KR101649003B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23Sulfur; Selenium; Tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063Periodont
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

(A) 글루콘산 구리, 황산 구리 및 그 수화물로부터 선택되는 1종 이상의 구리 화합물과, (B) 베타인형 양성 계면활성제와, (C) 에리스리톨, 크실리톨 및 만니톨로부터 선택되는 1종 이상의 당알코올을 구강용 조성물에 배합한다. 본 발명에 의하면, 치주병 개선 효과의 실효감인 잇몸에의 충분한 수렴감 부여 효과를 가지며, 또한, 구리 화합물 특유의 불쾌한 쓴맛 개선 효과 및 구강 점막 자극의 억제 효과가 발휘되고, 사용감에 우수한 구강용 조성물을 제공할 수 있다.(A) at least one copper compound selected from copper gluconate, copper sulfate and its hydrate, (B) betaine-type amphoteric surfactant, and (C) at least one sugar alcohol selected from erythritol, xylitol and mannitol To the composition for oral cavity. ADVANTAGE OF THE INVENTION According to this invention, it has the effect of providing sufficient convergence to the gum which is an effective feeling of periodontal disease improvement effect, and also exhibits the unpleasant bitterness improvement effect peculiar to a copper compound, and the inhibitory effect of oral mucosal irritation, and is excellent in a feeling. Can be provided.

Description

구강용 조성물{COMPOSITION FOR ORAL CAVITY}Composition for oral cavity {COMPOSITION FOR ORAL CAVITY}

본 발명은, 치주병 개선 효과의 실효감인 잇몸에의 충분한 수렴감(收斂感) 부여 효과를 가지며, 또한, 구리 화합물 특유의 불쾌한 쓴맛 개선 효과와 구강 점막 자극의 억제 효과를 발휘하고, 사용감에 우수한 구리 화합물을 함유하는 구강용 조성물에 관한 것이다.
This invention has the effect of providing sufficient convergence to the gum which is an effective feeling of the periodontal disease improvement effect, and exhibits the unpleasant bitterness improvement effect peculiar to a copper compound, and the inhibitory effect of oral mucosal irritation, and is excellent in a feeling of use. It relates to a composition for oral cavity containing a copper compound.

종래, 글루콘산 구리, 구연산 구리, 황산 구리 등의 구리 화합물에 항균 효과, 구취 제거 효과 및 플라그 형성 저지 효과가 있기 때문에, 구리 화합물을 배합한 구강용 조성물이 여러가지 제안되어 있고, 구리 화합물 유래의 효과의 개선이나 변색 방지를 위한 기술이 여러가지 제안되어 있다(특허 문헌 1 내지 5 ; 일본 특개평2-212413호 공보, 일본 특개평8-310928호 공보, 일본 특허 제2882017호 공보, 일본 특표평10-505831호 공보, 일본 특개2003-231621호 공보 참조).Background Art Conventionally, various oral compositions containing copper compounds have been proposed since copper compounds such as copper gluconate, copper citrate and copper sulfate have antibacterial effects, bad breath removal effects, and plaque formation inhibiting effects, and are derived from copper compounds. A variety of techniques have been proposed for improving or preventing discoloration (Patent Documents 1 to 5; Japanese Patent Laid-Open No. 2-212413, Japanese Patent Laid-Open No. 8-310928, Japanese Patent No. 2882017 and Japanese Patent Laid-Open No. 10-). 505831, Japanese Patent Laid-Open No. 2003-231621).

일반적으로 치마제(dentifrice)나 치주병 치료약 등에서는, 치주병 개선 효과의 실효감으로서 잇몸의 수렴감이 유효하고, 수렴 작용을 갖는 성분으로서 구리 화합물이 바람직하게 사용된다.Generally in dentifrice, periodontal disease treatment drug, etc., a feeling of convergence of a gum is effective as an effect of a periodontal disease improvement effect, and a copper compound is used suitably as a component which has a convergence effect.

그러나, 구리 화합물은, 쓴맛이나 금속 맛 등의 불쾌한 맛을 가지며, 또한, 구강 점막 자극을 갖기 때문에, 구리 화합물을 그 효과가 만족하게 발휘할 수 있는데 충분한 양으로 구강용 조성물에 배합하면 사용감이 저하된다는 문제가 있다. 지금까지 많은 해결책이 제안되어 있고, 출원인은, 구리 등의 금속 이온 방출 화합물에 멘톨 유도체 등을 배합함으로써, 금속 맛을 개선할 수 있음을 특허 문헌 6(일본 특개2003-137755호 공보)에 제안하였다.However, since the copper compound has an unpleasant taste such as bitterness or metal taste, and has oral mucosal irritation, the copper compound can be satisfactorily exhibited in effect. there is a problem. Many solutions have been proposed so far, and the applicant has proposed in Patent Document 6 (Japanese Patent Laid-Open No. 2003-137755) that a metal taste can be improved by incorporating a menthol derivative or the like into a metal ion-releasing compound such as copper. .

그렇지만, 본 발명자들의 검토에 의하면, 구리 화합물 유래의 쓴맛 등의 불쾌한 맛을 개선하면, 동시에 수렴감 부여 효과도 손상되어 버리기 때문에 실효감이 부족한 것이어서, 종래의 사용감 개선 기술은, 이 점에서 아직도 개선의 여지가 있었다. 한편으로, 구리 화합물 유래의 구강 점막 자극을 억제하면, 수렴감 부여 효과가 억제되어 버리기 때문에, 구리 화합물 유래의 만족스러운 수렴감을 손상시키는 일 없이 구강 점막 자극을 억제하는 것도 곤란하였다.However, according to the studies of the present inventors, if the unpleasant taste such as bitterness derived from the copper compound is improved, the effect of imparting convergence is also impaired, and thus the effectiveness is insufficient, and the conventional feeling improvement technique is still improved in this respect. There was room. On the other hand, when the oral mucosa stimulation derived from a copper compound is suppressed, the effect of converging feeling is suppressed. Therefore, it is also difficult to suppress the oral mucosa stimulation without impairing the satisfactory convergence feeling derived from the copper compound.

따라서, 구리 화합물 유래의 불쾌한 쓴맛 개선 효과 및 구강 점막 자극의 억제 효과와, 잇몸에의 충분한 수렴감 부여 효과를 동시에 겸비할 수 있는 기술의 개발이 요망되고 있다.Therefore, the development of the technique which can simultaneously have the unpleasant bitterness improvement effect derived from a copper compound, the inhibitory effect of oral mucosal irritation, and the effect of providing sufficient convergence to a gum is desired.

특허 문헌 1 : 일본 특개평2-212413호 공보Patent Document 1: Japanese Patent Laid-Open No. 2-212413 특허 문헌 2 : 일본 특개평8-310928호 공보Patent Document 2: Japanese Patent Application Laid-Open No. 8-310928 특허 문헌 3 : 일본 특허 제2882017호 공보Patent Document 3: Japanese Patent No. 2882017 특허 문헌 4 : 일본 특표평10-505831호 공보Patent Document 4: Japanese Patent Application Laid-Open No. 10-505831 특허 문헌 5 : 일본 특개2003-231621호 공보Patent Document 5: Japanese Patent Application Laid-Open No. 2003-231621 특허 문헌 6 : 일본 특개2003-137755호 공보Patent Document 6: Japanese Patent Application Laid-Open No. 2003-137755 특허 문헌 7 : 일본 특개2000-297022호 공보Patent Document 7: Japanese Patent Application Laid-Open No. 2000-297022 특허 문헌 8 : 일본 특개2008-150335호 공보Patent Document 8: Japanese Patent Application Laid-Open No. 2008-150335 특허 문헌 9 : 일본 특개2007-320894호 공보Patent Document 9: Japanese Patent Application Laid-Open No. 2007-320894

본 발명은, 치주병 개선 효과의 실효감인 잇몸에의 충분한 수렴감 부여 효과를 가지며, 또한, 구리 화합물 특유의 불쾌한 쓴맛 개선 효과 및 구강 점막 자극의 억제 효과를 발휘하고, 사용감에 우수한 구리 화합물을 함유하는 구강용 조성물을 제공하는 것을 목적으로 한다.
This invention has the effect of providing sufficient convergence to the gum which is an effective feeling of the periodontal disease improvement effect, and exhibits the unpleasant bitterness improvement effect peculiar to a copper compound, and the inhibitory effect of oral mucosal irritation, and contains the copper compound excellent in usability. It is an object to provide a composition for oral cavity.

본 발명자들은, 상기 목적을 달성하기 위해 예의 연구를 거듭한 결과, (A) 글루콘산 구리, 황산 구리 및 그 수화물로부터 선택되는 1종 이상의 구리 화합물과, (B) 베타인형 양성 계면 활성제와, (C) 에리스리톨, 크실리톨 및 만니톨로부터 선택되는 1종 이상의 당알코올을 병용하여 구강용 조성물에 배합함에 의해, 구리 화합물 유래의 불쾌한 쓴맛 개선 효과 및 구강 점막 자극의 억제 효과와, 잇몸에의 충분한 수렴감 부여 효과를 겸비할 수 있음을 발견하였다.MEANS TO SOLVE THE PROBLEM The present inventors earnestly researched in order to achieve the said objective, As a result, (A) 1 or more types of copper compounds chosen from copper gluconate, copper sulfate, and its hydrate, (B) a betaine type amphoteric surfactant, ( C) By combining at least one sugar alcohol selected from erythritol, xylitol and mannitol in combination with the composition for oral cavity, an unpleasant bitterness improvement effect derived from a copper compound and an inhibitory effect on oral mucosal irritation and sufficient convergence to the gums It has been found that the effect can be combined.

구리 화합물 함유의 구강용 조성물에 있어서, 구리 화합물 유래의 쓴맛, 구강 점막 자극, 수렴감은, 구리 화합물이 구강 내의 점막과 상호작용한 결과, 생긴다. 즉, 상기한 바와 같이 구리 화합물 함유의 구강용 조성물에 있어서, 구리 화합물 유래의 쓴맛 등의 불쾌한 맛이나 구강 점막 자극을 억제시키면, 동시에 수렴감 부여 효과도 손상되어 버리는 것은, 구리 화합물과 구강 내의 점막과의 상호작용을 변화시켰기 때문이라고 생각된다. 이에 대해, 본 발명에서는, 글루콘산 구리, 황산 구리 또는 그 수화물에, 베타인형 양성 계면활성제와 당알코올이 협동적으로 작용하고, 구리 화합물과 구강 내의 점막과의 상호작용이 상기와는 다르도록 변화함에 의해, 구리 화합물 유래의 쓴맛이 개선되고, 구강 점막 자극이 억제되는 동시에, 잇몸에의 충분한 수렴감 부여 효과를 유지할 수 있다고 추측된다.In the composition for oral cavity containing a copper compound, the bitterness, oral mucosa irritation, and convergence feeling derived from a copper compound arise as a result of the copper compound interacting with the mucous membrane in an oral cavity. That is, as mentioned above, in the composition for oral cavity containing a copper compound, if unpleasant taste, such as bitterness derived from a copper compound, and oral mucosal irritation are suppressed, the effect of converging feeling will also be impaired at the same time. I think it's because I changed the interaction with. On the other hand, in this invention, a betaine type amphoteric surfactant and a sugar alcohol cooperate cooperatively with copper gluconate, copper sulfate, or its hydrate, and the interaction of a copper compound and the mucous membrane in an oral cavity differs from the above. By doing so, the bitterness derived from a copper compound improves, oral mucosal irritation is suppressed, and it is guessed that the effect of providing sufficient convergence to a gum can be maintained.

이와 같은 본 발명의 작용 효과는, 후술의 실시예로부터도 분명하다. 본 발명은, 그 구성요건의 어느 하나를 결여하는 경우나, 베타인형 양성 계면활성제 대신에 아미노산형의 양성 계면활성제를 사용한 경우, 당알코올이라도 소르비톨이나 글리세린을 상기 (C)성분 대신에 사용한 경우에는 달성할 수가 없고, 본 발명의 구성요건의 전부를 충족시킴에 의해 달성할 수 있다.Such effects of the present invention are also apparent from the examples described later. When the present invention lacks any one of its constituent requirements, or when an amino acid type amphoteric surfactant is used in place of a betaine amphoteric surfactant, and saccharide or sorbitol is used in place of the component (C), It cannot be achieved and can be achieved by satisfying all of the structural requirements of the present invention.

또한, 구강용 조성물에의 배합 성분으로서 당알코올은 공지이고, 통상 보습제 등으로서 배합된다. 또한, 당알코올을 배합함으로써 폴리페놀 함유 식물 추출물에 의한 제제의 변색을 개선한 기술(특허 문헌 7 ; 일본 특개2000-297022호 공보), 불소 화합물과 라우릴황산 나트륨 및 트리메틸글리신을 함유하는 조성물에 에리스리톨을 배합함으로써 경시 보존 안정성을 개선한 기술(특허 문헌 8 ; 일본 특개2008-150335호 공보)이나, 비스글리신산 구리 및 크실리톨을 조합시킴으로써 구강 질환 개선 효과를 나타내는 조성물이 얻어지는(특허 문헌 4) 등이 제안되어 있다. 또한, 구강용 조성물에 양성 계면활성제를 배합하는 기술로서는, 불소 화합물 함유의 치마 조성물에 라우릴황산 나트륨과 카티온성 폴리머와 베타인형 양성 계면활성제를 배합함으로써, 불소 화합물의 구강 내 체류성, 사용감 등을 높인 기술(특허 문헌 9 ; 일본 특개2007-320894호 공보) 등이 제안되어 있다. 또한, 출원인은, 구리 화합물을 함유하는 구강용 조성물에, 보습제로서 환원당 함유량이 0.2질량% 이하의 당알코올을 배합하는 기술(특허 문헌 1), 또한, 양성 계면활성제를 배합하는 기술(특허 문헌 3)을 제안하였다. 이들 기술은, 구리 화합물에 유래하는 경시(經時)로의 변색 방지와 구취 제거 효과의 유지를 가능하게 한 것이고, 본 발명과는 해결 과제가 서로 다르고, 어느 것에도 본 발명의 구성, 그 기술적 사상 및 작용 효과는 나타나고 있지 않다.Moreover, sugar alcohol is well-known as a compounding component to the composition for oral cavity, and is mix | blended normally as a moisturizing agent or the like. In addition, by combining sugar alcohols, a technique for improving discoloration of the preparation by a polyphenol-containing plant extract (Patent Document 7; Japanese Patent Application Laid-Open No. 2000-297022), to a composition containing a fluorine compound, sodium lauryl sulfate and trimethylglycine By combining erythritol, a composition showing an oral disease improvement effect can be obtained by combining a technique (Patent Document 8; Japanese Patent Application Laid-Open No. 2008-150335) with erythritol or copper bisglycinate and xylitol (Patent Document 4). ) And the like have been proposed. Moreover, as a technique which mix | blends an amphoteric surfactant with a composition for oral cavity, the fluorine compound containing sodium lauryl sulfate, a cationic polymer, and a betaine type amphoteric surfactant are mix | blended with the skirt composition containing fluorine compound, and the oral retention property of a fluorine compound, a feeling, etc. (Patent Document 9; Japanese Patent Application Laid-Open No. 2007-320894) and the like have been proposed. Moreover, the applicant has the technique (patent document 1) which mix | blends sugar alcohol whose reducing sugar content is 0.2 mass% or less as a moisturizing agent to the composition for oral cavity containing a copper compound, and the technique which mix | blends an amphoteric surfactant (patent document 3). ) Is proposed. These techniques enable the prevention of discoloration over time derived from a copper compound and the maintenance of bad breath removal effects, and the problems are different from the present invention. And no effect is shown.

이와 같이 구리 화합물을 함유하는 구강용 조성물에 관해서는 여러가지의 제안이 있고, 당알코올이나 양성 계면활성제는 구강용 조성물의 배합 성분으로서 알려져 있다. 그러나, 글루콘산 구리, 황산 구리 또는 그 수화물을 함유하는 구강용 조성물에, 베타인형 양성 계면활성제와 당알코올인 에리스리톨, 크실리톨, 또는 만니톨을 조합시켜서 배합함에 의해, 구리 화합물 유래의 우수한 수렴감 부여 효과를 손상시키는 일 없이, 구리 화합물 유래의 불쾌한 쓴맛 및 구강 점막 자극을 만족하게 개선할 수 있는 것은, 본 발명자들의 새로운 연구결과이다.Thus, various proposals have been made regarding the composition for oral cavity containing a copper compound, and sugar alcohol and an amphoteric surfactant are known as a compounding component of an oral composition. However, by combining a betaine type amphoteric surfactant and sugar alcohol erythritol, xylitol, or mannitol in combination with a composition for oral cavity containing copper gluconate, copper sulfate, or a hydrate thereof, an excellent convergence feeling derived from a copper compound It is a new study result of the present inventors that the unpleasant bitterness and oral mucosal irritation derived from a copper compound can be satisfactorily improved without impairing the imparting effect.

따라서 본 발명은,Therefore,

(A) 글루콘산 구리, 황산 구리 및 그 수화물로부터 선택되는 1종 이상의 구리 화합물과,(A) at least one copper compound selected from copper gluconate, copper sulfate and hydrates thereof,

(B) 베타인형 양성 계면활성제와,(B) a betaine amphoteric surfactant,

(C) 에리스리톨, 크실리톨 및 만니톨로부터 선택되는 1종 이상의 당알코올(C) at least one sugar alcohol selected from erythritol, xylitol and mannitol

을 함유하여 이루어지는 것을 특징으로 하는 구강용 조성물을 제공한다.
It provides a composition for oral cavity comprising the.

본 발명의 구리 화합물 함유의 구강용 조성물은, 치주병 개선 효과의 실효감인 잇몸에의 충분한 수렴감 부여 효과를 가지며, 또한, 구리 화합물 특유의 불쾌한 쓴맛 개선 효과 및 구강 점막 자극의 억제 효과가 발휘되고, 사용감에 우수하다.
The copper compound-containing composition for oral cavity of the present invention has a sufficient astringent imparting effect to the gum which is a feeling of effectiveness of the periodontal disease improving effect, and also exhibits an unpleasant bitterness improvement effect peculiar to the copper compound and an inhibitory effect on oral mucosal irritation. Excellent in feeling.

이하, 본 발명에 대해 더욱 상세히 설명한다. 본 발명의 구강용 조성물은, (A) 글루콘산 구리, 황산 구리 및 그 수화물로부터 선택되는 구리 화합물과, (B) 베타인형 양성 계면활성제와, (C) 에리스리톨, 크실리톨 및 만니톨로부터 선택되는 1종 이상의 당알코올을 함유하여 이루어지는 것을 특징으로 한다.Hereinafter, the present invention will be described in more detail. The composition for oral cavity of this invention is chosen from (A) copper gluconate, a copper compound chosen from copper sulfate, and its hydrate, (B) a betaine type amphoteric surfactant, (C) erythritol, xylitol, and mannitol. It is characterized by containing one or more sugar alcohols.

(A)성분인 구리 화합물로서는, 글루콘산 구리, 황산 구리가 사용되고, 1종 단독으로도 2종을 병용하여도 좋다. 글루콘산 구리 및 황산 구리는, 각각 무수물이라도, 수화물이라도 좋다. 수화물로서는, 예를 들면 황산 구리 5수화물, 3수화물, 1수화물 등의 결정수를 포함하는 수화물을 사용할 수 있다.As a copper compound which is (A) component, copper gluconate and copper sulfate may be used and may be used individually by 1 type or in combination of 2 types. Copper gluconate and copper sulfate may be anhydrides or hydrates, respectively. As a hydrate, the hydrate containing crystal water, such as copper sulfate pentahydrate, a trihydrate, and a monohydrate, can be used, for example.

구리 화합물의 배합량은, 화합물 중의 구리로서 조성물 전체의 0.0026 내지 0.51%(질량%, 이하 마찬가지), 특히 0.013 내지 0.26%, 특히 0.026 내지 0.26%가 바람직하다. 배합량이 0.0026% 미만에서는 구리 화합물 유래의 수렴감 부여 효과가 충분 발휘되지 않는 경우가 있고, 0.51%를 초과하면 쓴맛 개선 효과를 충분히 발휘시키는 것이 곤란해지고, 사용감이 만족하게 개선되지 않는 경우가 있다.As for the compounding quantity of a copper compound, 0.0026 to 0.51% (mass% or less) of the whole composition as copper in a compound is especially 0.013 to 0.26%, Especially 0.026 to 0.26% is preferable. If the blending amount is less than 0.0026%, the convergence feeling-derived effect derived from the copper compound may not be sufficiently exhibited. If the blending amount exceeds 0.51%, it may be difficult to sufficiently exhibit the bitterness improving effect, and the usability may not be satisfactorily improved.

(B)성분인 베타인형 양성 계면활성제로서는, 라우릴베타인, 스테아릴베타인, 라우릴디메틸아미노아세트산 베타인, 스테아릴디메틸아미노아세트산 베타인, 2-알킬-N-카르복시메틸-N-히드록시에틸이미다졸리늄베타인, N-라우로일-N'-카르복시메틸-N'-히드록시에틸에틸렌디아민나트륨, 라우린산 아미드프로필베타인, 야자유지방산 아미드프로필베타인, 라우릴히드록시술포베타인 등을 들 수 있다. 그 중에서, 라우릴디메틸아미노아세트산 베타인, 야자유지방산 아미드프로필베타인, 2-알킬-N-카르복시메틸-N-히드록시에틸이미다졸리늄베타인, N-라우로일-N'-카르복시메틸-N'-히드록시에틸에틸렌디아민나트륨으로부터 선택되는 것이 바람직하다. 이들 베타인형 양성 계면활성제는, 1종 단독으로 또는 2종 이상을 병용하여 사용할 수 있다.As a betaine type amphoteric surfactant which is (B) component, a lauryl betaine, a stearyl betaine, a lauryl dimethylamino acetic acid betaine, a stearyl dimethyl amino acetic acid betaine, 2-alkyl-N-carboxymethyl-N-hydride Oxyethyl imidazolinium betaine, N-lauroyl-N'-carboxymethyl-N'-hydroxyethylethylenediamine sodium, lauric acid amide propyl betaine, palm oil fatty acid amide propyl betaine, lauryl hydroxy And syruppobetaine. Among them, lauryl dimethylamino acetic acid betaine, palm oil fatty acid amide propyl betaine, 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine, N-lauroyl-N'-carboxymethyl It is preferably selected from -N'-hydroxyethylethylenediamine sodium. These betaine type amphoteric surfactants can be used individually by 1 type or in combination of 2 or more types.

베타인형 양성 계면활성제는, 시판품을 사용할 수 있고, 예를 들면 산요카세이공업 사제의 2-알킬-N-카르복시메틸-N-히드록시에틸이미다졸리늄베타인(상품명 레본105), N-라우로일-N'-카르복시메틸-N'-히드록시에틸에틸렌디아민나트륨(상품명 레본101-H), 야자유지방산 아미드프로필베타인액(液)(상품명 레본2000), 닛꼬 케미칼즈 사제의 라우릴디메틸아미노아세트산 베타인 수용액(상품명 NIKKOL AM-301) 등을 들 수 있다. 2-알킬-N-카르복시메틸-N-히드록시에틸이미다졸리늄베타인으로서는, 상품명 에나지콜C-40H로서 라이온(주)에서 판매되고 있는 2-야자유알킬-N-카르복시메틸-N-히드록시에틸이미다졸리늄베타인나트륨 수용액을 사용할 수도 있다.A commercially available product can be used for a betaine type amphoteric surfactant, For example, 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine (brand name Levon 105) and N-laux manufactured by Sanyo Kasei Co., Ltd. Loyl-N'-carboxymethyl-N'-hydroxyethylethylenediamine sodium (brand name Levon 101-H), palm oil fatty acid amide propyl betaine liquid (brand name Levon 2000), lauryl dimethylamino by Nikko Chemicals Betaine acetate aqueous solution (brand name NIKKOL AM-301) etc. are mentioned. As 2-alkyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine, 2-palm oil alkyl-N-carboxymethyl-N-hydroxy sold by Lion Co., Ltd. as brand name Enazol C-40H Aqueous sodium imidazolinium betaine solution may also be used.

베타인형 양성 계면활성제의 배합량은, 조성물 전체의 0.01 내지 5%, 특히 0.05 내지 2%, 특히 0.1 내지 1%가 바람직하다. 배합량이 0.01% 미만에서는 구강 점막 자극의 억제 효과가 충분 발휘되지 않는 경우가 있고, 5%를 초과하면 계면활성제에 의한 구강 점막 자극의 문제가 생기고, 또한, 쓴맛 개선 효과가 충분히 발휘되지 않는 경우가 있다.As for the compounding quantity of a betaine type amphoteric surfactant, 0.01-5%, especially 0.05-2%, especially 0.1-1% of the whole composition are preferable. If the blending amount is less than 0.01%, the inhibitory effect of oral mucosal irritation may not be sufficiently exhibited. If the amount exceeds 5%, the problem of oral mucosal irritation caused by the surfactant may occur, and the bitter taste improvement effect may not be sufficiently exhibited. have.

(C)성분은, 에리스리톨, 크실리톨 및 만니톨로부터 선택되는 당알코올이다. 이들 당알코올은, 1종을 단독으로 사용하여도, 2종 또는 3종을 병용하여도 좋다. 2종을 병용하는 경우는, 에리스리톨과 크실리톨과의 병용이 바람직하다.(C) component is sugar alcohol chosen from erythritol, xylitol, and mannitol. These sugar alcohols may be used individually by 1 type, or may use 2 or 3 types together. When using two types together, combination of erythritol and xylitol is preferable.

(C)성분인 당알코올의 배합량은, 조성물 전체의 2 내지 50%, 특히 5 내지 30%가 바람직하고, 특히 10 내지 30%가 가장 바람직하다. 배합량이 2% 미만에서는 쓴맛 개선 효과가 충분히 발휘되지 않는 경우가 있고, 50%를 초과하면 구리 화합물에 의한 수렴감 부여 효과가 저해되고, 또한, 구강 점막 자극의 억제 효과가 충분 발휘되지 않는 경우가 있다.As for the compounding quantity of the sugar alcohol which is (C) component, 2-50%, especially 5-30% of the whole composition are preferable, and 10-30% are the most preferable especially. If the blending amount is less than 2%, the bitterness improving effect may not be sufficiently exhibited. If the blending amount exceeds 50%, the effect of imparting convergence by the copper compound is inhibited, and the effect of suppressing oral mucosal irritation is not sufficiently exhibited. have.

본 발명의 구강용 조성물은, 연치마, 윤제치마, 액체치마 등의 치마제, 세구제, 겔제, 연고제, 입안 청량제, 양치질용 정제, 구강용 파스타, 껌 등의 각종 제형으로 조제할 수 있지만, 특히 치마제 및 겔제, 특히 겔제로 바람직하게 조제된다. 이와 같은 제형으로 조제하면, 본 발명의 효과를 보다 유효하게 발현시킬 수 있다. 이들 제제는, 상기 필수 성분에 더하여, 필요에 따라 그 제형에 응한 그 밖의 성분을 본 발명의 효과를 해치지 않는 범위에서 배합할 수 있고, 통상의 방법으로 조제할 수 있다.The composition for oral cavity of the present invention can be prepared in various formulations, such as a skirt, a mouthwash, a gel, an ointment, a mouthwash, a toothbrush, a toothpaste, a mouthwash, a gum such as a toothpaste, a polished skirt and a liquid skirt. It is particularly preferably formulated as a dentifrice and a gel, in particular a gel. When prepared with such a formulation, the effects of the present invention can be more effectively expressed. In addition to the above essential ingredients, these preparations may be blended with other ingredients in accordance with the formulation, if necessary, within a range that does not impair the effects of the present invention, and may be prepared by conventional methods.

그 밖의 성분으로서는, 예를 들면 치마제의 경우에는, 각종 연마제, 습윤제, 점결제, 계면활성제 및 필요에 응하여 감미료, 항료, 착색제, 방부제, pH 조정제, 그 밖의 유효 성분 등을 배합할 수 있다. 겔제의 경우에는, 습윤제, 점결제, 계면활성제 및 필요에 응하여 감미료, 항료, 착색제, 방부제, pH 조정제, 알코올, 유성(油性) 성분, 그 밖의 유효 성분 등을 배합할 수 있다.As other components, for example, in the case of a dentifrice, various abrasives, wetting agents, caking additives, surfactants, and sweeteners, colorants, coloring agents, preservatives, pH adjusters, other active ingredients, etc. can be mix | blended as needed. In the case of a gel agent, a wetting agent, a caking additive, surfactant, and a sweetener, a coloring agent, a coloring agent, a preservative, a pH adjuster, an alcohol, an oily component, other active ingredients, etc. can be mix | blended as needed.

연마제로서는, 침강성 실리카, 실리카겔, 알루미노실리케이트, 제오라이트, 지르코노실리케이트, 제 2 인산 칼슘·2수화물 및 무수물, 피로인산 칼슘, 탄산 칼슘, 수산화 알미늄, 알루미나, 탄산 마그네슘, 제 3 인산 마그네슘, 불용성 메타인산 나트륨, 불용성 메타인산 칼륨, 산화 티탄, 하이드록시 아파타이트, 합성 수지계 연마제 등을 들 수 있다(배합량 ; 통상, 조성물 전체에 대해 5 내지 50%).As the abrasive, precipitated silica, silica gel, aluminosilicate, zeolite, zirconosilicate, dicalcium phosphate dihydrate and anhydride, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, magnesium triphosphate, insoluble meta Sodium phosphate, insoluble potassium metaphosphate, titanium oxide, hydroxyapatite, synthetic resin-based abrasives, and the like (mixture amount; usually 5 to 50% based on the total composition).

습윤제로서는, (C)성분인 당알코올 이외의 것, 예를 들면 소르비톨, 글리세린, 프로필렌글리콜, 폴리에틸렌글리콜, 1,3-부틸렌글리콜 등의 다가알코올을 들 수 있다. 습윤제를 배합하는 경우, 그 배합량은 통상 10 내지 50%이다.Examples of the humectant include polyhydric alcohols such as sugar alcohols other than the (C) component, for example, sorbitol, glycerin, propylene glycol, polyethylene glycol, and 1,3-butylene glycol. When mix | blending a humectant, the compounding quantity is 10 to 50% normally.

점결제로서는, 카르복시메틸셀룰로오스나트륨, 히드록시에틸셀룰로오스 등의 셀룰로오스 유도체, 알긴산 나트륨, 알긴산 프로필렌글리콜에스테르 등의 알긴산 유도체, 구아고무, 크산탄고무, 아라비아고무 등의 고무류, 카라기난, 젤라틴, 폴리비닐알코올, 폴리아크릴산 나트륨, 카르복시비닐 폴리머, 폴리비닐피롤리돈 등의 합성 점결제 등을 들 수 있다(배합량 통상 0.5 내지 10%).Examples of the caking agent include cellulose derivatives such as sodium carboxymethyl cellulose and hydroxyethyl cellulose, alginic acid derivatives such as sodium alginate and propylene glycol esters, guar rubber, xanthan rubber, gum arabic, carrageenan, gelatin, and polyvinyl alcohol. And synthetic caking additives such as sodium polyacrylate, carboxyvinyl polymer, and polyvinylpyrrolidone (compound amount usually 0.5 to 10%).

계면활성제로서는, (B)성분인 베타인형 양성 계면활성제 이외의 것, 예를 들면 비이온성 계면활성제, 아니온성 계면활성제 및 카티온성 계면활성제를 배합할 수 있다.As surfactant, things other than the betaine type amphoteric surfactant which is (B) component, for example, a nonionic surfactant, anionic surfactant, and cationic surfactant can be mix | blended.

비이온성 계면활성제로서는, 소르비탄지방산 에스테르, 폴리옥시에틸렌소르비탄지방산 에스테르, 자당지방산 에스테르 등의 당알코올지방산 에스테르류, 글리세린지방산 에스테르, 폴리글리세린지방산 에스테르, 폴리옥시에틸렌글리세린지방산 에스테르, 폴리에틸렌글리콜지방산 에스테르 등의 다가알코올지방산 에스테르, 폴리옥시에틸렌알킬에테르, 폴리옥시에틸렌폴리옥시프로필렌 공중합체, 폴리옥시에틸렌알킬페닐에테르, 폴리옥시에틸렌경화피마자유 등의 에테르형 또는 에스테르형의 계면활성제, 라우린산 디에탄올아미드 등의 지방산 알칸올아미드류를 들 수 있다.Examples of nonionic surfactants include sugar alcohol fatty acid esters such as sorbitan fatty acid esters, polyoxyethylene sorbitan fatty acid esters, and sucrose fatty acid esters, glycerin fatty acid esters, polyglycerol fatty acid esters, polyoxyethylene glycerin fatty acid esters, and polyethylene glycol fatty acid esters. Ether type or ester type surfactant, such as polyhydric alcohol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene copolymer, polyoxyethylene alkyl phenyl ether, polyoxyethylene hardened castor oil, lauric acid di Fatty acid alkanolamides, such as ethanolamide, are mentioned.

아니온성 계면활성제로서는, 라우릴황산 나트륨, 미리스틸황산 나트륨 등의 알킬황산염, N-라우로일살코신나트륨, N-미리스토일살코신나트륨 등의 N-아실살코신나트륨, 도데실벤젠술폰산 나트륨, 수소첨가 코코넛지방산 모노글리세리드 모노황산 나트륨, 라우릴술포아세트산 나트륨, N-팔미토일글루타민산 나트륨 등의 N-아실글루타민산염, N-메틸-N-아실타우린나트륨, N-메틸-N-아실알라닌나트륨, α-올레핀술폰산 나트륨 등을 들 수 있다. 카티온성 계면활성제로서는, 알킬암모늄, 알킬벤질암모늄염 등을 들 수 있다.Examples of the anionic surfactants include alkyl sulfates such as sodium lauryl sulfate and sodium myristyl sulfate, sodium N-acyl salcosine, sodium dodecylbenzene sulfonate, such as sodium N-lauroyl salcosine, and sodium N-myristoyl sarcosine, N-acyl glutamate, such as hydrogenated coconut fatty acid sodium monoglyceride monosulfate, sodium lauryl sulfoacetate, sodium N-palmitoyl glutamate, sodium N-methyl-N-acyltaurine, sodium N-methyl-N-acylalanine, sodium α-olefin sulfonate; and the like. Examples of cationic surfactants include alkyl ammonium and alkylbenzyl ammonium salts.

임의 성분으로서 이들 계면활성제를 배합하는 경우, 그 배합량은 통상 0.01 내지 2%이다.When mix | blending these surfactant as an arbitrary component, the compounding quantity is 0.01 to 2% normally.

또한, 본 발명에서는, 아니온성 계면활성제, 특히 라우릴황산 나트륨 등의 알킬 황산염은, 사용감을 저하시키는 경향이 있기 때문에 배합하지 않는 쪽이 바람직하다. 아니온성 계면활성제를 배합하는 경우, 그 배합량은 0.5% 이하, 특히 0 내지 0.1%가 바람직하지만, 0%라도 좋다. 무배합인 것이 특히 바람직하다.In addition, in this invention, since anionic surfactant, especially alkyl sulfates, such as sodium lauryl sulfate, tends to reduce usability, it is more preferable not to mix | blend. When mix | blending anionic surfactant, the compounding quantity is 0.5% or less, Especially 0 to 0.1% are preferable, but 0% may be sufficient. It is especially preferable that it is no compound.

감미료로서는, 사카린나트륨, 스테비오사이드, 스테비아 엑기스, 파라메톡시신나믹알데히드, 네오헤스피리딜히드로칼콘, 페릴라르틴 등을 들 수 있다.Examples of sweeteners include sodium saccharin, stevioside, stevia extract, paramethoxycinnamicaldehyde, neohespyridylhydrochalcone, peraryllatin, and the like.

착색제로서는, 청색 1호(FD&C Blue No. 1(42090)), 황색 4호(FD&C Yellow No. 5(19140)), 이산화 티탄 등을 들 수 있다. 방부제로서는, 팔라옥시안식향산 에스테르, 안식향산 나트륨 등의 안식향산 또는 그 염 등을 들 수 있다. 항료로서는, l-멘톨, 카르본, 아네톨, 리모넨 등의 테르펜류 또는 그 유도체나, 페퍼민트유 등을 들 수 있다.As a coloring agent, Blue No. 1 (FD & C Blue No. 1 (42090)), Yellow No. 4 (FD & C Yellow No. 5 (19140)), titanium dioxide, etc. are mentioned. As a preservative, benzoic acid, such as a palaoxybenzoic acid ester and sodium benzoate, or its salt, etc. are mentioned. Examples of the drug include terpenes such as l-menthol, carbon, anetol, and limonene, derivatives thereof, peppermint oil, and the like.

pH 조정제로서는, 구연산, 푸마르산, 사과산, 주석산, 젖산 등을 들 수 있다.Citric acid, fumaric acid, malic acid, tartaric acid, lactic acid, etc. are mentioned as a pH adjuster.

알코올로서는, 에탄올 등의 탄소수 3 이하의 저급 알코올을 들 수 있다. 알코올을 배합하는 경우, 그 배합량은 통상 1 내지 20%이다.Examples of the alcohol include lower alcohols having 3 or less carbon atoms such as ethanol. When mix | blending an alcohol, the compounding quantity is 1 to 20% normally.

유성 성분으로서는, 유동 파라핀, 경질 유동 파라핀, 파라핀왁스, 세레신, 마이크로크리스탈린왁스, 스쿠알란, 스쿠알렌 등의 탄화 수소유, 라우린산, 미리스틴산, 파르미틴산, 스테아린산, 라울로레인산, 올레인산, 아라키돈산, 리놀산, 리놀렌산, 리시놀산 등의 지방산, 아마인유, 호마유, 사플라워유, 대두유, 옥수수유, 유채유, 면실유, 올리브유, 동백유, 피마자유, 카카오지(脂), 팜유, 야자유 등의 식물유, 우지, 돈지, 마지(馬脂), 양지 등의 동물유 등을 들 수 있다. 이들 중에서도, 제제의 구강 내에의 체류성의 점에서 탄화 수소유가 바람직하고, 보다 바람직하게는 유동파라핀, 경질유동파라핀이다. 유성 성분을 배합하는 경우, 그 배합량은, 통상 0.1 내지 10%이다.As the oily component, hydrocarbon oils such as liquid paraffin, hard liquid paraffin, paraffin wax, ceresin, microcrystalline wax, squalane and squalene, lauric acid, myristic acid, parmitic acid, stearic acid, lauloric acid, oleic acid, Fatty acids such as arachidonic acid, linoleic acid, linolenic acid, and ricinolic acid, linseed oil, sesame oil, soybean oil, soybean oil, corn oil, rapeseed oil, cottonseed oil, olive oil, camellia oil, castor oil, cacao oil, palm oil and palm oil And animal oils such as beef tallow, pork tallow, marzipan and yangji. Among these, hydrocarbon oil is preferable at the point of retention in the oral cavity of a preparation, More preferably, they are liquid paraffin and hard fluid paraffin. When mix | blending an oil-based component, the compounding quantity is 0.1 to 10% normally.

유효 성분으로서는, (A)성분인 구리 화합물 이외의 것, 예를 들면 아스코르빈산염, 토코페롤에스테르 등의 비타민류, 덱스트라나제, 무타나제, 리소자임 등의 효소, 황백 엑기스, 황금 엑기스, 정자 엑기스 등의 생약 성분, 염화 세틸피리디늄, 염화 벤제토늄, 염화 벤잘코늄, 염화 데쿠알니늄, 염산 크로르헥시딘, 글루콘산 크로르헥시딘, 트리클로산, 이소프로필메틸페놀, 히노기 티올 등의 살균제, 염화 나트륨, 폴리인산 나트륨, 메타인산 나트륨, 올도인산 나트륨, 트리폴리인산 나트륨, 젖산 알루미늄, 키토산 등의 무기 염류나 유기 염류 등을 들 수 있다. 또한, 이들 유효 성분의 배합량은, 본 발명의 효과를 방해하지 않는 범위에서 유효량으로 할 수 있다.As an active ingredient, things other than the copper compound which is (A) component, For example, vitamins, such as ascorbate and tocopherol ester, enzymes, such as dextranase, mutanase, and lysozyme, sulfur white extract, golden extract, and sperm Herbicides such as extracts, fungicides such as cetylpyridinium chloride, benzetonium chloride, benzalkonium chloride, decuanium chloride, chlorhexidine hydrochloride, gluconate chlorhexidine, triclosan, isopropylmethylphenol, and hygithiol And inorganic salts and organic salts such as sodium chloride, sodium polyphosphate, sodium metaphosphate, sodium oleate, sodium tripolyphosphate, aluminum lactate and chitosan. In addition, the compounding quantity of these active ingredients can be made an effective amount in the range which does not prevent the effect of this invention.

실시예Example

이하, 실시예 및 비교예를 나타내어 본 발명을 구체적으로 설명하지만, 본 발명은 하기 실시예로 제한되는 것이 아니다. 또한, 이하의 예에서 배합량은 모두 질량%이다. 또한, 형태가 수용액의 성분에 관해서는, 표 안도 포함하여 모두 순분(純分) 환산의 배합량을 나타내었다.Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not limited to a following example. In addition, in the following example, all compounding quantities are the mass%. In addition, about the component of aqueous solution, the form showed the compounding quantity of pure part conversion including the inside of a table | surface.

[실시예, 비교예][Example, Comparative Example]

표 1 내지 4에 표시하는 조성의 구강용 조성물(겔제)을 조제하고, 전문가 패널 5명의 잇몸에 구강용 조성물 약 0.5g을 손가락으로 도포하였다. 직후의 잇몸에 대한 수렴감 부여 효과, 구강 점막 자극의 억제 효과, 쓴맛 개선 효과를, 각각 하기에 나타내는 4단계의 평점 기준으로 관능 평가를 행한 후, 하기 평가 기준에 따라 평가하였다. 결과를 표 1 내지 5에 표시한다. 또한, 배합 성분의 상세를 표 6에 표시한다.The composition for oral cavity (gel) of the composition shown to Tables 1-4 was prepared, and about 0.5 g of the composition for oral cavity was apply | coated to the gums of five expert panels with the finger. After the sensory evaluation by the four-step evaluation criteria shown below, the convergence feeling effect, the oral mucosal irritation effect, and the bitter taste improvement effect with respect to the gum immediately after, were evaluated according to the following evaluation criteria. The results are shown in Tables 1-5. In addition, the detail of a compounding component is shown in Table 6.

수렴감 부여 효과 ;Convergence effect;

평점grade

4점 : 수렴감을 느낀다4 points | pieces: A feeling of convergence is felt.

3점 : 수렴감을 약간 느낀다3 points | pieces: A feeling of convergence is felt a little.

2점 : 수렴감을 거의 느끼지 않는다2 points | pieces: A feeling of convergence is hardly felt

1점 : 수렴감을 느끼지 않는다1 point: It does not feel a convergence

수렴감 부여 효과의 평가 기준 ;Criterion for evaluation of convergence effect;

◎ : 수렴감 부여 효과의 평균점 3.5점 이상 4.0점 이하◎: 3.5 points or more and 4.0 points or less

○ : 수렴감 부여 효과의 평균점 3.0점 이상 3.5점 미만○: 3.0 points or more and less than 3.5 points

△ : 수렴감 부여 효과의 평균점 2.0점 이상 3.0점 미만△: 2.0 points or more and less than 3.0 points

× : 수렴감 부여 효과의 평균점 2.0점 미만×: less than 2.0 points on average of convergence

구강 점막 자극의 억제 효과 ;Inhibitory effect of oral mucosal irritation;

평점grade

4점 : 전혀 자극을 느끼지 않는다4 points | pieces: It does not feel a stimulus at all.

3점 : 자극을 거의 느끼지 않는다3 points | pieces: I hardly feel a stimulus.

2점 : 자극을 약간 느낀다2 points | pieces: I feel a little stimulation.

1점 : 자극을 느낀다1 point | piece: I feel a stimulus

구강 점막 자극의 억제 효과의 평가 기준 ;Evaluation criteria for the inhibitory effect of oral mucosal stimulation;

◎ : 구강 점막 자극의 억제 효과의 평균점 3.5점 이상 4.0점 이하◎: 3.5 points or more and 4.0 points or less of the average point of the inhibitory effect of oral mucosa stimulation

○ : 구강 점막 자극의 억제 효과의 평균점 3.0점 이상 3.5점 미만(Circle): Average point 3.0 or more and less than 3.5 points of the inhibitory effect of oral mucosal irritation

△ : 구강 점막 자극의 억제 효과의 평균점 2.0점 이상 3.0점 미만(Triangle | delta): 2.0 points or more and less than 3.0 points of average points of the inhibitory effect of oral mucosal irritation

× : 구강 점막 자극의 억제 효과의 평균점 2.0점 미만×: less than 2.0 points on average of the inhibitory effect of oral mucosa stimulation

쓴맛 개선 효과 ;Bitterness improvement effect;

평점grade

4점 : 전혀 쓴맛을 느끼지 않는다4 points: It does not feel bitter at all.

3점 : 쓴맛을 거의 느끼지 않는다3 points: hardly feel bitter taste

2점 : 쓴맛을 약간 느낀다2 points | pieces: A little bitter taste

1점 : 쓴맛을 느끼고, 또는 자극이 강하다1 point | piece: Feel bitterness, or strong irritation

쓴맛 개선 효과의 평가 기준 ;Evaluation criteria of bitterness improvement effect;

◎ : 쓴맛 개선 효과의 평균점 3.5점 이상 4.0점 이하◎: 3.5 points or more and 4.0 points or less

○ : 쓴맛 개선 효과의 평균점 3.0점 이상 3.5점 미만(Circle): Average point 3.0 or more and less than 3.5 points of bitterness improvement effect

△ : 쓴맛 개선 효과의 평균점 2.0점 이상 3.0점 미만(Triangle | delta): 2.0 points or more and less than 3.0 points of average points of the bitterness improvement effect

× : 쓴맛 개선 효과의 평균점 2.0점 미만X: Less than 2.0 points on average of bitterness improvement effect

Figure pct00001
Figure pct00001

Figure pct00002
Figure pct00002

Figure pct00003
Figure pct00003

Figure pct00004
Figure pct00004

Figure pct00005
Figure pct00005

Figure pct00006
Figure pct00006

Claims (4)

(A) 글루콘산 구리, 황산 구리 및 그 수화물로부터 선택되는 1종 이상의 구리 화합물과,
(B) 베타인형 양성 계면활성제와,
(C) 에리스리톨, 크실리톨 및 만니톨로부터 선택되는 1종 이상의 당알코올을 함유하여 이루어지는 것을 특징으로 하는 구강용 조성물.
(A) at least one copper compound selected from copper gluconate, copper sulfate and hydrates thereof,
(B) a betaine amphoteric surfactant,
(C) Oral composition containing at least 1 type of sugar alcohol selected from erythritol, xylitol, and mannitol.
제 1항에 있어서,
베타인형 양성 계면활성제가, 라우릴디메틸아미노아세트산 베타인, 야자유지방산 아미드프로필베타인, 2-알킬-N-카르복시메틸-N-히드록시에틸이미다졸리늄베타인 및 N-라우로일-N'-카르복시메틸-N'-히드록시에틸에틸렌디아민나트륨으로부터 선택되는 1종 또는 2종 이상인 것을 특징으로 하는 구강용 조성물.
The method of claim 1,
Betaine-type amphoteric surfactants include lauryldimethylaminoacetic acid betaine, palm oil fatty acid amidepropylbetaine, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazoliniumbetaine and N-lauroyl-N Oral composition characterized by the 1 type (s) or 2 or more types chosen from sodium "-carboxymethyl-N" -hydroxyethylethylenediamine.
제 1항 또는 제 2항에 있어서,
(A)성분을 구리로서 0.013 내지 0.26질량%, (B)성분을 0.05 내지 2질량%, (C)성분을 5 내지 30질량% 함유하는 것을 특징으로 하는 구강용 조성물.
3. The method according to claim 1 or 2,
(A) Component contains 0.013-0.26 mass% as copper, 0.05-2 mass% of (B) component, and 5-30 mass% of (C) component, The composition for oral cavity characterized by the above-mentioned.
제 1항 내지 제 3항 중 어느 한 항에 있어서,
겔제로서 조제되는 것을 특징으로 하는 구강용 조성물.
4. The method according to any one of claims 1 to 3,
A composition for oral cavity, which is prepared as a gel agent.
KR1020117022572A 2009-03-30 2010-03-23 Composition for oral cavity KR101649003B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009081716 2009-03-30
JPJP-P-2009-081716 2009-03-30

Publications (2)

Publication Number Publication Date
KR20110133573A true KR20110133573A (en) 2011-12-13
KR101649003B1 KR101649003B1 (en) 2016-08-17

Family

ID=42827983

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117022572A KR101649003B1 (en) 2009-03-30 2010-03-23 Composition for oral cavity

Country Status (5)

Country Link
JP (1) JP5930713B2 (en)
KR (1) KR101649003B1 (en)
CN (1) CN102365077B (en)
HK (1) HK1163509A1 (en)
WO (1) WO2010113688A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170094133A (en) * 2014-12-12 2017-08-17 라이온 가부시키가이샤 Composition for use in oral cavity

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019230710A1 (en) 2018-05-29 2019-12-05 ライオン株式会社 Composition for oral cavity
WO2020016926A1 (en) * 2018-07-17 2020-01-23 日本ゼトック株式会社 Nonaqueous composition for oral cavity
EP3603626A1 (en) * 2018-07-31 2020-02-05 Mucosa Innovations, S.L. Composition for use in the prevention and/or treatment of the genitourinary mucosa

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171909A (en) * 1981-04-15 1982-10-22 Lion Corp Composition for oral cavity
JPH02212413A (en) 1989-02-10 1990-08-23 Lion Corp Composition for oral cavity
JPH08310928A (en) 1995-05-15 1996-11-26 Lion Corp Dentifrice composition
JPH10505831A (en) 1994-09-15 1998-06-09 ザ、プロクター、エンド、ギャンブル、カンパニー Oral composition
JP2882017B2 (en) 1990-09-19 1999-04-12 ライオン株式会社 Oral composition
JP2000297022A (en) 1999-04-12 2000-10-24 Lion Corp Composition for oral cavity
JP2003137755A (en) 2001-11-02 2003-05-14 Lion Corp Composition for oral cavity
JP2003231621A (en) 2002-02-06 2003-08-19 Lion Corp Composition for oral cavity for preventing foul breath
JP2007320894A (en) 2006-05-31 2007-12-13 Lion Corp Toothpaste composition
JP2008150335A (en) 2006-12-19 2008-07-03 Lion Corp Dentifrice composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2132033B1 (en) * 1997-11-06 2000-03-01 Dentaid Sa ORAL COMPOSITION FOR THE TREATMENT OF HALITOSIS.
WO2003045344A2 (en) * 2001-11-28 2003-06-05 The Procter & Gamble Company Dentifrice compositions
US7601002B2 (en) * 2004-03-29 2009-10-13 Colgate-Palmolive Co Dental whitening method
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
JP2007008824A (en) * 2005-06-28 2007-01-18 Lion Corp Composition for oral cavity
JP4919060B2 (en) * 2007-06-28 2012-04-18 ライオン株式会社 Oral composition and algin dipine inhibitor

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171909A (en) * 1981-04-15 1982-10-22 Lion Corp Composition for oral cavity
JPH02212413A (en) 1989-02-10 1990-08-23 Lion Corp Composition for oral cavity
JP2882017B2 (en) 1990-09-19 1999-04-12 ライオン株式会社 Oral composition
JPH10505831A (en) 1994-09-15 1998-06-09 ザ、プロクター、エンド、ギャンブル、カンパニー Oral composition
JPH08310928A (en) 1995-05-15 1996-11-26 Lion Corp Dentifrice composition
JP2000297022A (en) 1999-04-12 2000-10-24 Lion Corp Composition for oral cavity
JP2003137755A (en) 2001-11-02 2003-05-14 Lion Corp Composition for oral cavity
JP2003231621A (en) 2002-02-06 2003-08-19 Lion Corp Composition for oral cavity for preventing foul breath
JP2007320894A (en) 2006-05-31 2007-12-13 Lion Corp Toothpaste composition
JP2008150335A (en) 2006-12-19 2008-07-03 Lion Corp Dentifrice composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170094133A (en) * 2014-12-12 2017-08-17 라이온 가부시키가이샤 Composition for use in oral cavity

Also Published As

Publication number Publication date
JPWO2010113688A1 (en) 2012-10-11
CN102365077B (en) 2013-10-16
HK1163509A1 (en) 2012-09-14
JP5930713B2 (en) 2016-06-08
WO2010113688A1 (en) 2010-10-07
CN102365077A (en) 2012-02-29
KR101649003B1 (en) 2016-08-17

Similar Documents

Publication Publication Date Title
JP5251350B2 (en) Dentifrice composition
JP5672651B2 (en) Mouthwash composition
KR20120086685A (en) Dentifrice composition
JP2019052110A (en) Oral composition
WO2013094504A1 (en) Oral composition
WO2015099152A1 (en) Oral composition
WO2016093279A1 (en) Composition for use in oral cavity
JP5488096B2 (en) Oral composition
KR20110133573A (en) Composition for oral cavity
WO2016006647A1 (en) Composition for use in oral cavity
JP2020011951A (en) Oral composition
JP5509631B2 (en) Application gel composition for oral cavity
JP7124403B2 (en) dentifrice composition
CN111902125B (en) Oral composition and bitterness improver of alpha-olefin sulfonate
JP5496526B2 (en) Oral composition
JP7167659B2 (en) dentifrice composition
JP6825339B2 (en) Oral composition
JP2012077032A (en) Oral composition
JP2004051535A (en) Composition for oral cavity
JP2010143842A (en) Dentifrice composition
JP5880298B2 (en) Liquid oral composition
JP2013112655A (en) Dentifrice composition
JPH08301743A (en) Dentifrice composition
JP2006069987A (en) Tooth-brushing composition
JPWO2018097122A1 (en) Oral composition

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20190722

Year of fee payment: 4